Global Neurovascular Embolectomy Device Market Growth 2023-2029

Global Neurovascular Embolectomy Device Market Growth 2023-2029

Neurovascular embolectomy device is used during an embolectomy procedure. These devices are used for removal of emboli, obstructing the blood circulation, surgically. Usually, embolectomy is the least preferred option for treatment and other involved therapeutic options are anticoagulation and thrombolysis. Neurovascular device market has undergone a demand-shift with respect to products and techniques. Doctors want to adopt instruments and techniques that offer higher window for stroke treatment with high success rate and minimal post-surgical impact. This is supported by the fact that demand for bare platinum coils is growing at a higher pace in comparison to coated coils. This is mainly due to high costs of coated coils and their less improved clinical outcomes compared to bare platinum coils. Additionally, stroke treatment involves high healthcare expenditure that drives the focus on development of economical treatment techniques.

LPI (LP Information)' newest research report, the “Neurovascular Embolectomy Device Industry Forecast” looks at past sales and reviews total world Neurovascular Embolectomy Device sales in 2022, providing a comprehensive analysis by region and market sector of projected Neurovascular Embolectomy Device sales for 2023 through 2029. With Neurovascular Embolectomy Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurovascular Embolectomy Device industry.

This Insight Report provides a comprehensive analysis of the global Neurovascular Embolectomy Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurovascular Embolectomy Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Neurovascular Embolectomy Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurovascular Embolectomy Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurovascular Embolectomy Device.

The global Neurovascular Embolectomy Device market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Neurovascular Embolectomy Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Neurovascular Embolectomy Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Neurovascular Embolectomy Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Neurovascular Embolectomy Device players cover Boston Scientific Corporation, Cook Medical, DePuy Synthes, Edwards Lifesciences Corporation, iVascular SLU, LeMaitre Vascular, Inc, Medtronic, Straub Medical AG and Teleflex Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Neurovascular Embolectomy Device market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Aspiration Systems
Stent Retreival Systems

Segmentation by application
Hospital
Medical Center
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boston Scientific Corporation
Cook Medical
DePuy Synthes
Edwards Lifesciences Corporation
iVascular SLU
LeMaitre Vascular, Inc
Medtronic
Straub Medical AG
Teleflex Inc

Key Questions Addressed in this Report

What is the 10-year outlook for the global Neurovascular Embolectomy Device market?

What factors are driving Neurovascular Embolectomy Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Neurovascular Embolectomy Device market opportunities vary by end market size?

How does Neurovascular Embolectomy Device break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.